The Drug Enforcement Administration issued a series of regulations that would allow more flexibility for doctors looking to prescribe controlled substances like amphetamine, oxycodone, or buprenorphine online.
One (RIN 1117-AB40) of the three measures released by the agency Wednesday would introduce a new licensure program allowing vetted practitioners to prescribe controlled substances online without an in-person evaluation.
The proposed rule would mark the first time that clinicians can apply for special registration since the adoption of the Ryan Haight Online Pharmacy Consumer Protection Act in 2008.
Under the DEA’s special registration program, providers looking to dispense schedule II-V ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.